NCT04512456

Brief Summary

Patients living with HIV (PLWHIV) have compromised muscle metaboreflex, which can cause exercise intolerance. This randomized controlled clinical trial will verify the effects of regular exercise on autonomic and hemodynamic responses to muscle ergoreflex activation in these patients. PLWHIV without regular physical exercise will be randomly assigned into an exercise training or a control group. The exercise training group will undergo regular physical exercise during 12 weeks (60-min session performed 3 times/wk with moderate intensity), while the control group will keep inactive. Another group consisted of inactive HIV-uninfected group will be included. The primary endpoints will be blood pressure and autonomic markers in response to the Stroop Color-Word Test and the activation of muscle ergoreflex, by means of the post-exercise circulatory arrest (PECA), which will be performed with and without the topical application of a capsaicin-based analgesic balm. Secondary endpoints will include heart rate, peripheral vascular resistance, stroke volume, cardiac output, blood lactate concentration, anthropometrics, and handgrip strength. The active and inactive PLWHIV groups will be evaluated before and after the exercise training, while the healthy group only at baseline.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P25-P50 for not_applicable hiv-infections

Timeline
8mo left

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Aug 2024Dec 2026

First Submitted

Initial submission to the registry

August 7, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 13, 2020

Completed
4 years until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

2.4 years

First QC Date

August 7, 2020

Last Update Submit

March 23, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from Baseline Blood Pressure at 3 months

    Blood pressure will be assessed by a digital sphygmomanometer.

    Baseline and 3 months of follow-up

  • Change from Baseline Heart Rate Variability at 3 months

    Heart rate variability will be assessed by a heart rate monitor.

    Baseline and 3 months of follow-up

Secondary Outcomes (7)

  • Change from Baseline Heart Rate at 3 months

    Baseline and 3 months of follow-up

  • Change from Baseline Peripheral Vascular Resistance at 3 months

    Baseline and 3 months of follow-up

  • Change from Baseline Stroke Volume at 3 months

    Baseline and 3 months of follow-up

  • Change from Baseline Cardiac Output at 3 months

    Baseline and 3 months of follow-up

  • Change from Baseline Blood Lactate at 3 months

    Baseline and 3 months of follow-up.

  • +2 more secondary outcomes

Study Arms (3)

Active HIV-infected patients

EXPERIMENTAL

Exercise training

Behavioral: Exercise training

Inactive HIV-infected patients

NO INTERVENTION

No intervention.

Healthy subjects

NO INTERVENTION

No intervention.

Interventions

Exercise training performed during 12 weeks, 3 sessions per week of 60 minutes of strength and aerobic exercises.

Active HIV-infected patients

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • diagnosis of HIv infection for at least 5 years;
  • use of combined antiretroviral therapy for at least 3 years;
  • asymptomatic and free from opportunistic diseases at enrollment.

You may not qualify if:

  • regular physical exercise;
  • malnutrition;
  • presence of coronary artery disease, ischemic diseases, pulmonary disease, diabetes, Chagas disease, tuberculosis, heart failure, hypertension;
  • using pacemakers and/or antidepressant, antiarrhythmic or antihypertensive medication, especially beta-blockers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rio de Janeiro State University

Rio de Janeiro, Rio de Janeiro, 20550-900, Brazil

RECRUITING

Related Publications (1)

  • Gama G, Dos Santos Rangel MV, de Oliveira Coelho VC, Paz GA, de Matos CVB, Silva BP, Lopes GO, Lopes KG, Farinatti P, Borges JP. The effects of exercise training on autonomic and hemodynamic responses to muscle metaboreflex in people living with HIV/AIDS: A randomized clinical trial protocol. PLoS One. 2022 Mar 18;17(3):e0265516. doi: 10.1371/journal.pone.0265516. eCollection 2022.

MeSH Terms

Conditions

HIV Infections

Interventions

Exercise

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Julana P Borges, Dr

    Rio de Janeiro State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Juliana P Borges, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: HIV+active group will perform exercise training, while HIV+inactive and HIV- groups will not undergo intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 7, 2020

First Posted

August 13, 2020

Study Start

August 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 27, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations